These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22843119)

  • 1. MYC and PIM2 co-expression in mouse bone marrow cells readily establishes permanent myeloid cell lines that can induce lethal myeloid sarcoma in vivo.
    Jang SH; Chung HY
    Mol Cells; 2012 Aug; 34(2):201-8. PubMed ID: 22843119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.
    Agrawal-Singh S; Koschmieder S; Gelsing S; Stocking C; Stehling M; Thiede C; Thoennissen NH; Köhler G; Valk PJ; Delwel R; Mills K; Bäumer N; Tickenbrock L; Hansen K; Berdel WE; Müller-Tidow C; Serve H
    Blood; 2010 Jun; 115(22):4507-16. PubMed ID: 20215640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model.
    Jang SH; Lee S; Chung HY
    PLoS One; 2015; 10(11):e0143240. PubMed ID: 26606454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
    Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
    Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation.
    Agrawal S; Koschmieder S; Bäumer N; Reddy NG; Berdel WE; Müller-Tidow C; Serve H
    Leukemia; 2008 Jan; 22(1):78-86. PubMed ID: 17943165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
    Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
    Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
    Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
    Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
    Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo hematopoietic Myc activation directs a transcriptional signature in endothelial cells within the bone marrow microenvironment.
    Franke K; Vilne B; Prazeres da Costa O; Rudelius M; Peschel C; Oostendorp RA; Keller U
    Oncotarget; 2015 Sep; 6(26):21827-39. PubMed ID: 26308666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes.
    Wernig G; Gonneville JR; Crowley BJ; Rodrigues MS; Reddy MM; Hudon HE; Walz C; Reiter A; Podar K; Royer Y; Constantinescu SN; Tomasson MH; Griffin JD; Gilliland DG; Sattler M
    Blood; 2008 Apr; 111(7):3751-9. PubMed ID: 18216297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of murine bone marrow cells with combined v-raf-v-myc oncogenes yields clonally related mature B cells and macrophages.
    Principato M; Cleveland JL; Rapp UR; Holmes KL; Pierce JH; Morse HC; Klinken SP
    Mol Cell Biol; 1990 Jul; 10(7):3562-8. PubMed ID: 2162474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
    Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
    Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.
    Fu JF; Yen TH; Chen Y; Huang YJ; Hsu CL; Liang DC; Shih LY
    Int J Cancer; 2013 Oct; 133(8):1792-802. PubMed ID: 23564351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
    Fu JF; Yen TH; Huang YJ; Shih LY
    Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
    Sugihara E; Shimizu T; Kojima K; Onishi N; Kai K; Ishizawa J; Nagata K; Hashimoto N; Honda H; Kanno M; Miwa M; Okada S; Andreeff M; Saya H
    Oncogene; 2012 Jun; 31(23):2849-61. PubMed ID: 21986948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the cell cycle and the expression of c-myc and transferrin receptor genes during induced myeloid differentiation.
    Barker KA; Newburger PE
    Exp Cell Res; 1990 Jan; 186(1):1-5. PubMed ID: 2404770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.